i-Optics BV:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:i-Optics BV - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7223
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
I-Optics BV (I-Optics) is a medical device company that manufactures and distributes optical devices. The company offers Cassini, a corneal shape analyzer that measures the axis and magnitude of corneal astigmatism and EasyScan, a zero-dilation retinal imaging system to diagnose retinal diseases including diabetic retinopathy, age-related macular degeneration, and glaucoma. I-Optics’ Cassini product offers a suite of examinations required for toric and multifocal IOL implantation, which includes corneal topography, mesopic, photopic pupillometry and color photography for diagnostic purpose. The company offers solutions such as retina and cornea imaging and eye diagnosis solutions. It sells products through a network of distributors in Switzerland, Italy, Spain, the Netherlands, France and Belgium. I-Optics is headquartered in the Hague, the Netherlands.

i-Optics BV – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
i-Optics BV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
i-Optics BV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
i-Optics BV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
i-Optics BV, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
i-Optics BV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
i-Optics BV, Medical Equipment, Deal Details 10
Venture Financing 10
i-Optics Raises US$15 Million In Series D Financing 10
Partnerships 12
Hoya Vision Care Enters into Distribution Agreement with i-Optics 12
TrueVision Systems and i-Optics Enter into Partnership 13
Debt Offering 14
i-Optics Raises USD10.8 Million in Private Placement of Debt Financing 14
i-Optics BV – Key Competitors 15
i-Optics BV – Key Employees 16
i-Optics BV – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Product News 18
Oct 04, 2017: Record 12 clinical studies on improving cataract surgery outcomes with Cassini to be presented during ESCRS 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
i-Optics BV, Medical Equipment, Key Facts 2
i-Optics BV, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
i-Optics BV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
i-Optics BV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
i-Optics BV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
i-Optics BV, Deals By Market, 2012 to YTD 2018 8
i-Optics BV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
i-Optics Raises US$15 Million In Series D Financing 10
Hoya Vision Care Enters into Distribution Agreement with i-Optics 12
TrueVision Systems and i-Optics Enter into Partnership 13
i-Optics Raises USD10.8 Million in Private Placement of Debt Financing 14
i-Optics BV, Key Competitors 15
i-Optics BV, Key Employees 16

List of Figures
i-Optics BV, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
i-Optics BV, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
i-Optics BV, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
i-Optics BV, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
i-Optics BV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
i-Optics BV, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
i-Optics BV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
i-Optics BV, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[i-Optics BV:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GlycoNex Inc (4168):製薬・医療:M&Aディール及び事業提携情報
    Summary GlycoNex Inc (GlycoNex) is a drug discovery company that conducts research and development in glycosphingolipid antigen and human monoclonal antibody technologies to develop cancer drugs. The company carries out antibody drug development through its various technology platforms such as glyco …
  • Outokumpu Oyj:企業のM&A・事業提携・投資動向
    Outokumpu Oyj - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Outokumpu Oyj Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Takaful Emarat – Insurnace (P.S.C):企業の戦略・SWOT・財務情報
    Takaful Emarat - Insurnace (P.S.C) - Strategy, SWOT and Corporate Finance Report Summary Takaful Emarat - Insurnace (P.S.C) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Luxshare Precision Industry Co., Ltd. (002475):企業の財務・戦略的SWOT分析
    Luxshare Precision Industry Co., Ltd. (002475) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Energy Recovery Inc (ERII):企業の財務・戦略的SWOT分析
    Energy Recovery Inc (ERII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • ERG Renew SpA-エネルギー分野:企業M&A・提携分析
    Summary ERG Renew S.p.A. (ERG Renew), formerly Entad S.p.A., a subsidiary of ERG S.p.A, is a power company that generates electricity from renewable sources. The company generates electricity mainly through wind. ERG Renew and its subsidiaries operate in Italy, France, Bulgaria/Romania, Germany, and …
  • Huron Consulting Group Inc:企業の戦略・SWOT・財務分析
    Huron Consulting Group Inc - Strategy, SWOT and Corporate Finance Report Summary Huron Consulting Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Barry-Wehmiller Companies, Inc.:企業の戦略・SWOT・財務情報
    Barry-Wehmiller Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Barry-Wehmiller Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Enel Green Power SpA:企業の戦略的SWOT分析
    Enel Green Power SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Teikoku Seiyaku Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Teikoku Seiyaku Co Ltd (Teikoku Seiyaku) is a medical device company that develops, manufactures and distributes medicated and medically related supplies. The company offers Chinese medicine, other medicinal products, quasi-drugs, cosmetics, hot sensation plaster, transdermal indomethacin me …
  • The E. W. Scripps Company:戦略・SWOT・企業財務分析
    The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report Summary The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Praxair, Inc.:企業の戦略・SWOT・財務分析
    Praxair, Inc. - Strategy, SWOT and Corporate Finance Report Summary Praxair, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Napp Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Napp Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • OMV Petrom SA (SNP):企業の財務・戦略的SWOT分析
    OMV Petrom SA (SNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Spanish National Cancer Research Center-製薬・医療分野:企業M&A・提携分析
    Summary Spanish National Cancer Research Center (CNIO) is a medical research center that offers cancer research programs. The center is an integral cancer research institute which integrates basic and translational cancer research. It conducts various scientific programs which include molecular onco …
  • Guardant Health Inc (GH):企業の製品パイプライン分析2018
    Summary Guardant Health Inc (Guardant Health) is a non-invasive cancer diagnostics company that commercializes genomic liquid biopsy. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It offers Guardant360, a tool for early cancer detection …
  • Clevexel Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary Clevexel Pharma SAS (Clevexel) is a drug development company that develops drugs to treat diseases of the central nervous system. The company’s pipeline product portfolio includes CVXL-0107, a glutamate release inhibitor developed to improve the quality of life for Parkinson’s disease patien …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)-製薬・医療分野:企業M&A・提携分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Parexel International Corp:企業の戦略的SWOT分析
    Parexel International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Manitou Bf Sa:企業の戦略・SWOT・財務分析
    Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report Summary Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆